Report Categories
View AllRecent Articles
View All
Xenon Pharmaceuticals XENE Unveils Robust Azetukalner Phase III Data Q3 NDA Filing Plans at Bloom Burton Conference
Is ITT ITT a once in a decade opportunity Edges Lower 20260508
JDcom Inc JD Technical Golden Cross and Upward Earnings Revisions Signal NearTerm Upside Potential
What Array UZE auditor changes mean for investors Q4 2025 Profit Disappoints